RecruitingNot ApplicableNCT07463963

Relevance of the Urine Bacterial Culture Performed Before TransUrethral Resection of the Bladder for Post-operative Febrile Urinary Tract Infections Prevention: a Non-inferiority Randomized Controlled Trial

Sponsor

Poitiers University Hospital

Enrollment

2,600 participants

Start Date

Jun 29, 2026

Study Type

INTERVENTIONAL

Conditions

Bladder Cancer Urinary Tract Infection Bacterial Transurethral Resection of the Bladder

Summary

The main objective of the study is to demonstrate that not performing a systematic UC before the TURB procedure is non-inferior to performing a systematic UC in terms of the incidence of febrile UTIs during the first 30 postoperative days

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying No intervention before TURB surgery and Urine bacterial Culture (UC) for people with bladder cancer, transurethral resection of the bladder, and other related conditions. The study is currently recruiting participants at 15 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTUrine bacterial Culture (UC)

Performing a systematic UC before the TURB surgery

OTHERNo intervention before TURB surgery

No Urine Culture before TURB Surgery

Locations(15)

Centre Hospitalier Universitaire d'Angers

Angers, France

Centre Hospitalier Universitaire de Grenoble Alpes

Grenoble, France

Centre Hospitalier de Chartres - Hôpital Louis Pasteur

Le Coudray, France

Centre Hospitalier Universitaire de Lille

Lille, France

Hospices Civils de Lyon

Lyon, France

Assistance Publique - Hôpitaux de Marseille - Hôpital Nord

Marseille, France

Centre Hospitalier Intercommunal de Mont de Marsan et du Pays des Sources

Mont-de-Marsan, France

Centre Hospitalier Universitaire de Nantes - Hotel Dieu

Nantes, France

AP-HP - Hôpital Universitaire Pitié-Salpêtrière

Paris, France

Hôpital Bichat Claude Bernard-APHP

Paris, France

CHU Poitiers - Service de chirurgie urologique

Poitiers, France

Clinique la Croix du Sud

Quint-Fonsegrives, France

Centre hospitalier universitaire de Bordeaux

Talence, France

Centre Hospitalier Régional et Universitaire de Tours - Bretonneau

Tours, France

Centre Hospitalier Régional et Universitaire de Nancy - Hôpitaux de Brabois

Vandœuvre-lès-Nancy, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07463963

Related Trials

Enfortumab Vedotin and Stereotactic Radiation for Localized, Cisplatin Ineligible Muscle Invasive Bladder Cancer

NCT063945701 location

A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)

NCT0741929571 locations

A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT0617247885 locations

SL-28 for Advanced Solid Tumours

NCT073417371 location

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas

NCT0721717112 locations